EP Vantage is a forward-looking comment and analysis service tailored to the needs of pharma and finance professionals, focusing on the events that will define the future of companies, products and therapy areas. Written by experienced journalists, EP Vantage provides timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. EP Vantage is powered by EvaluatePharma, the industry leader in consensus forecasts.
I am a former professional money manager and two bit economist who for 30 years managed assets and planned retirement years for clients in Santa Barbara. My expertise is in Autos and Biotech's, specifically oncology. My hobbies are Formula One, cooking, travel and abstract art.